Although insulin therapy provides potential benefits to the ischemic myocardium for AMI patients with hyperglycemia, current randomized trials assessing the effect of insulin-based therapy on prognosis failed to demonstrate consistent benefits of insulin-based therapy in this population. Here, INS is linked to Hyperglycemia.